Exhibit 3.5.3
STATE OF DELAWARE
CERTIFICATE OF AMENDMENT
OF CERTIFICATE OF INCORPORATION
The corporation organized and existing under and by virtue of the General Corporation Law of
the State of Delaware does hereby certify:
FIRST: That at a meeting of the Board of Directors of
Talecris Biotherapeutics, Inc.
resolutions were duly adopted setting forth a proposed amendment of the Certificate of
Incorporation of said corporation, declaring said amendment to be advisable and calling a meeting
of the stockholders of said corporation for consideration thereof. The resolution setting forth the
proposed amendment is as follows:
RESOLVED, that the Certificate of Incorporation of this corporation be amended
by changing the Article thereof numbered “FIRST ” so that, as
amended, said Article shall be and read as follows:
FIRST: The name of the corporation (hereinafter sometimes referred to as the “Corporation”) is:
Grifols Therapeutics Inc.
SECOND: That thereafter, pursuant to resolution of its Board of Directors, a
special meeting of the stockholders of said corporation was duly called and held upon notice in
accordance with Section 222 of the General Corporation Law of the State of Delaware at which
meeting the necessary number of shares as required by statute were voted in favor of the amendment.
THIRD: That said amendment was duly adopted in accordance with the provisions
of Section 242 of the General Corporation Law of the State of Delaware.
IN WITNESS WHEREOF, said corporation has caused this certificate to be
signed this 10th day of August, 2011.
| |
|
|
|
|
| |
|
|
| |
By: |
|
|
| |
|
Authorized Officer |
|
| |
|
Title: |
Executive Vice President, U.S. Operations
|
|
| |
|
Name: |
David I. Bell
Print or Type |
|